Open an Account
search icon
1
NOTIFICATIONS
Best Algo trading app in India
Bigul

MANGALAM DRUGS & ORGANICS LTD. - 532637 - Board Meeting Intimation for Inter-Alia To Consider And Approve The Audited Financial Results Of The Company For The Quarter / Year Ended March 31, 2020 Scheduled To Be Held On Monday, June 29, 2020.

 MANGALAM DRUGS & ORGANICS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/06/2020 ,inter alia, to consider and approve the Audited Financial Results of the Company for the quarter / year ended March 31, 2020.
21-06-2020
Bigul

MANGALAM DRUGS & ORGANICS LTD. - 532637 - Compliances-Reg.24(A)-Annual Secretarial Compliance

 Annual Secretarial Compliance Report for the Financial Year ended March 31,2020 as per the provisions of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No. CIR/CFD/CMD1/27/2019 dated February 8,2019.
15-06-2020
Bigul

MANGALAM DRUGS & ORGANICS LTD. - 532637 - Update On Development Of API Favipiravir

 Update on development of API Favipiravir
11-06-2020
Bigul

MANGALAM DRUGS & ORGANICS LTD. - 532637 - Update On Certificate Of Suitability (CEP) For Hydroxychloroquine Sulphate (HCQS).

 Update on Certificate of Suitability (CEP) for Hydroxychloroquine Sulphate (HCQS).
19-05-2020
Bigul

MANGALAM DRUGS & ORGANICS LTD. - 532637 - Shareholding for the Period Ended March 31, 2020

 Mangalam Drugs & Organics Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2020. For more details, kindly Click here
16-05-2020
Bigul

MANGALAM DRUGS & ORGANICS LTD. - 532637 - Certificate Under Regulation 40(9) / 40(10) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Half Year Ended March 31, 2020.

 Pursuant to Regulation 40(9) / 40(10) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby enclose the certificate for the half year ended March 31, 2020 issued by CS Sandeep Gandhi - Practicing Company Secretary.
13-05-2020
Bigul

MANGALAM DRUGS & ORGANICS LTD. - 532637 - Compliance Certificate Under Regulation 7(3) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Period Ended March 31, 2020.

 Compliance Certificate under Regulation 7(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, duly signed by the Compliance Officer of the Company and Authorised Representative of Link Intime India Private Limited (RTA) for the half year ended March 31, 2020.
13-05-2020
Bigul

MANGALAM DRUGS & ORGANICS LTD. - 532637 - Compliance Certificate Under Regulation 7(3) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Period Ended March 31, 2020.

 Compliance Certificate under Regulation 7(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, duly signed by the Compliance Officer of the Company and Authorised Representative of Link Intime India Private Limited (RTA) for the half year ended March 31, 2020.
13-05-2020
Bigul

MANGALAM DRUGS & ORGANICS LTD. - 532637 - Statement Of Investor Complaints For The Quarter Ended March 2020

 No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0101 Name of the Signatory :- CS Geeta KariraDesignation :- Company Secretary and Compliance Officer
07-05-2020
Bigul

MANGALAM DRUGS & ORGANICS LTD. - 532637 - Closure of Trading Window

 Closure of Trading Window
31-03-2020
Next Page
Close

Let's Open Free Demat Account